Literature DB >> 8174957

Failure of colonoscopic surveillance in ulcerative colitis.

D A Lynch1, A J Lobo, G M Sobala, M F Dixon, A T Axon.   

Abstract

A prospective surveillance programme for patients with longstanding (> = 8 years), extensive (> = splenic flexure) ulcerative colitis was undertaken between 1978 and 1990. It comprised annual colonoscopy with pancolonic biopsy. One hundred and sixty patients were entered into the programme and had 739 colonoscopies (4.6 colonoscopies per patient; 709 patient years follow up). Eight eight per cent of examinations reached the right colon. There was no procedure related death. One Dukes's A cancer was detected. Forty one patients (25%) defaulted. Of these 25 remain well; 13 are unaccounted for, and one died from colonic cancer. One patient had colectomy for medical reasons, and another died of carcinoma of the pancreas. Retrospectively an additional 16 eligible patients were identified who had not been recruited. Of these, 14 remain well, two are unaccounted for. None developed colonic cancer. Four patients refused colonoscopy. All remain well. Over the same period seven other cases of colonic cancer were found in association with ulcerative colitis, two in patients who had erroneously been diagnosed as having only proctitis and were therefore not entered into the programme, but were found at operation to have total colitis, one in a patient with colitis of seven years duration, and four patients who had previously attended the clinic but had been lost to follow up before 1978 and then had represented with new symptoms during the surveillance period. Thus, of the nine colitis related cancers diagnosed in this centre during the study period only one was detected by the surveillance programme. The results of this large study, a a review of published works, cast doubts on the effectiveness of colonoscopic surveillance programmes in detecting colorectal cancer in patients with ulcerative colitis.

Entities:  

Mesh:

Year:  1993        PMID: 8174957      PMCID: PMC1374357          DOI: 10.1136/gut.34.8.1075

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Compliance, cost, and common sense limit cancer control in colitis.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

Review 2.  The precarcinomatous phase of ulcerative colitis.

Authors:  R H Riddell
Journal:  Curr Top Pathol       Date:  1976

3.  Precancer and cancer in inflammatory bowel disease.

Authors:  B C Morson
Journal:  Pathology       Date:  1985-04       Impact factor: 5.306

4.  Cancer in colitis: assessment of the individual risk by clinical and histological criteria.

Authors:  J E Lennard-Jones; B C Morson; J K Ritchie; D C Shove; C B Williams
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

5.  Surveillance for colonic carcinoma in ulcerative colitis.

Authors:  E Rosenstock; R G Farmer; R Petras; M V Sivak; G B Rankin; B H Sullivan
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

6.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

7.  Cancer risk in extensive ulcerative colitis.

Authors:  J Kewenter; H Ahlman; L Hultén
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

8.  Cancer surveillance in ulcerative colitis. Experience over 15 years.

Authors:  J E Lennard-Jones; B C Morson; J K Ritchie; C B Williams
Journal:  Lancet       Date:  1983-07-16       Impact factor: 79.321

9.  Endoscopic surveillance for cancer in chronic ulcerative colitis.

Authors:  J A Fuson; R G Farmer; A Hawk; B H Sullivan
Journal:  Am J Gastroenterol       Date:  1980-02       Impact factor: 10.864

10.  Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis.

Authors:  R J Dickinson; M F Dixon; A T Axon
Journal:  Lancet       Date:  1980-09-20       Impact factor: 79.321

View more
  41 in total

1.  Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

Authors:  C H Lim; M F Dixon; A Vail; D Forman; D A F Lynch; A T R Axon
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

2.  Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

Authors:  J A Eaden; J F Mayberry
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

3.  Screening and surveillance for asymptomatic colorectal cancer in IBD.

Authors:  A Forbes; S Gabe; J E Lennard-Jones; K Wilkinson
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

4.  p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease.

Authors:  Jeffrey W Nathanson; Nicole E Yadron; Jeanne Farnan; Sydney Kinnear; John Hart; David T Rubin
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

Review 5.  Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

Authors:  Peter-Laszlo Lakatos; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

6.  The cancer "fear" in IBD patients: is it still REAL?

Authors:  T M Connelly; W A Koltun
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

Review 7.  How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis?

Authors:  R H Riddell
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

Review 8.  How do we assess the value of surveillance techniques in ulcerative colitis?

Authors:  C N Bernstein
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

Review 9.  Biology of colorectal cancer in ulcerative colitis.

Authors:  B A Lashner; B D Shapiro
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

10.  Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection.

Authors:  Venkataraman Subramanian; Sukhdev Chatu; Fabian Echterdiek; Ashwini Banerjee; Caroline Finlayson; Richard C G Pollok
Journal:  Dig Dis Sci       Date:  2016-07-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.